A Study About Modified RNA Vaccines Against Influenza in Healthy Adults

Clinical trial NCT06436703 · COMPLETED

Trial details

NCT number: NCT06436703
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2024-05-23
Primary completion: 2025-02-05
Enrollment: 1202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.